Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - OTHER OPERATING ACTIVITIES
Other Operating Activities APLS - Apellis Pharmaceuticals, Inc.
26.4 M
LAST VALUE
104.32%
2 YEAR CAGR
115.50%
5 YEAR CAGR
58.03%
10 YEAR CAGR